- Home
- LGVN vs ELBM Comparison
LGVN vs ELBM Comparison
Compare LGVN & ELBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- ELBM
- Stock Information
- Founded
- LGVN 2014
- ELBM 2011
- Country
- LGVN United States
- ELBM Canada
- Employees
- LGVN N/A
- ELBM N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- ELBM Industrial Machinery/Components
- Sector
- LGVN Health Care
- ELBM Miscellaneous
- Exchange
- LGVN Nasdaq
- ELBM Nasdaq
- Market Cap
- LGVN 27.6M
- ELBM 22.8M
- IPO Year
- LGVN 2021
- ELBM N/A
- Fundamental
- Price
- LGVN $1.40
- ELBM $1.05
- Analyst Decision
- LGVN Strong Buy
- ELBM Strong Buy
- Analyst Count
- LGVN 3
- ELBM 1
- Target Price
- LGVN $8.67
- ELBM $2.40
- AVG Volume (30 Days)
- LGVN 193.2K
- ELBM 324.1K
- Earning Date
- LGVN 05-13-2025
- ELBM 05-23-2025
- Dividend Yield
- LGVN N/A
- ELBM N/A
- EPS Growth
- LGVN N/A
- ELBM N/A
- EPS
- LGVN N/A
- ELBM N/A
- Revenue
- LGVN $2,392,000.00
- ELBM N/A
- Revenue This Year
- LGVN $1.30
- ELBM N/A
- Revenue Next Year
- LGVN $19.15
- ELBM N/A
- P/E Ratio
- LGVN N/A
- ELBM N/A
- Revenue Growth
- LGVN 237.38
- ELBM N/A
- 52 Week Low
- LGVN $0.77
- ELBM $0.91
- 52 Week High
- LGVN $6.40
- ELBM $2.83
- Technical
- Relative Strength Index (RSI)
- LGVN 37.54
- ELBM 32.44
- Support Level
- LGVN $1.44
- ELBM $1.06
- Resistance Level
- LGVN $1.62
- ELBM $1.18
- Average True Range (ATR)
- LGVN 0.13
- ELBM 0.14
- MACD
- LGVN -0.04
- ELBM -0.01
- Stochastic Oscillator
- LGVN 16.13
- ELBM 17.27
Stock Price Comparison Chart: LGVN vs ELBM
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About ELBM Electra Battery Materials Corporation
Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry.